JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.09B |
| 2 |
Broadcom
AVGO
|
+$1.03B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$970M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$877M |
| 5 |
Verizon
VZ
|
+$875M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.37B |
| 3 |
TWX
Time Warner Inc
TWX
|
+$764M |
| 4 |
IBM
IBM
|
+$737M |
| 5 |
Philip Morris
PM
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Financials | 14% |
| 3 | Technology | 12.71% |
| 4 | Healthcare | 9.7% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PRTK
2901
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $3.23M | ﹤0.01% |
316,634
+89,470
| +39% | +$1.01M |
2016 Q4
6 quarters
|
|
2902
iShares US Aerospace & Defense ETF
ITA
$12.2B
| $3.22M | ﹤0.01% |
33,480
+4,834
| +17% | +$479K |
2013 Q3
19 quarters
|
|
|
KDNY
2903
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $3.21M | ﹤0.01% |
91,855
-2,087
| -2% | -$80K |
2015 Q2
12 quarters
|
|
2904
Ingles Markets
IMKTA
$1.65B
| $3.21M | ﹤0.01% |
100,983
-77,199
| -43% | -$2.43M |
2015 Q1
13 quarters
|
|
2905
CALL
Kinder Morgan
KMI
$69.2B
| $3.21M | ﹤0.01% |
181,400
+81,400
| +81% | +$1.33M |
2014 Q3
15 quarters
|
|
2906
Vanguard Extended Market ETF
VXF
$30.6B
| $3.2M | ﹤0.01% |
27,201
+1,471
| +6% | +$171K |
2013 Q2
20 quarters
|
|
2907
CytomX Therapeutics
CTMX
$558M
| $3.2M | ﹤0.01% |
139,931
-61,130
| -30% | -$1.56M |
2016 Q4
6 quarters
|
|
2908
Oceaneering
OII
$4.41B
| $3.2M | ﹤0.01% |
125,661
+73,214
| +140% | +$1.64M |
2013 Q2
20 quarters
|
|
|
CLDT
2909
Chatham Lodging
CLDT
$637M
| $3.2M | ﹤0.01% |
150,614
-1,043,021
| -87% | -$20.8M |
2013 Q2
20 quarters
|
|
2910
CALL
Brunswick
BC
$4.24B
| $3.19M | ﹤0.01% |
+49,400
| New | +$3.08M |
2018 Q2
0 quarters
|
|
2911
Northwest Bancshares
NWBI
$2.22B
| $3.18M | ﹤0.01% |
183,081
-36,115
| -16% | -$616K |
2015 Q4
10 quarters
|
|
|
ATVI
2912
PUT
DELISTED
Activision Blizzard
ATVI
| $3.17M | ﹤0.01% |
41,600
| – | – |
2017 Q1
5 quarters
|
|
|
GWPH
2913
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.17M | ﹤0.01% |
22,746
+1,762
| +8% | +$250K |
2014 Q4
14 quarters
|
|
2914
Safety Insurance
SAFT
$1.53B
| $3.17M | ﹤0.01% |
37,091
+2,543
| +7% | +$211K |
2016 Q1
9 quarters
|
|
|
RAVN
2915
DELISTED
Raven Industries Inc
RAVN
| $3.16M | ﹤0.01% |
82,289
+1,054
| +1% | +$40.3K |
2016 Q3
7 quarters
|
|
2916
CALL
Medtronic
MDT
$110B
| $3.16M | ﹤0.01% |
36,900
| – | – |
2017 Q3
3 quarters
|
|
2917
PUT
Wayfair
W
$13.9B
| $3.15M | ﹤0.01% |
+26,500
| New | +$2.3M |
2018 Q2
0 quarters
|
|
|
VSM
2918
DELISTED
Versum Materials, Inc.
VSM
| $3.15M | ﹤0.01% |
84,702
-220,597
| -72% | -$8.41M |
2016 Q4
6 quarters
|
|
2919
Genworth Financial
GNW
$3.61B
| $3.15M | ﹤0.01% |
698,911
-1,339,263
| -66% | -$4.62M |
2013 Q2
20 quarters
|
|
|
DRYS
2920
DELISTED
DryShips Inc. Common Stock
DRYS
| $3.14M | ﹤0.01% |
+597,257
| New | +$2.46M |
2018 Q2
0 quarters
|
|
2921
Arcus Biosciences
RCUS
$3.11B
| $3.14M | ﹤0.01% |
256,538
+255,438
| +23,222% | +$4.01M |
2018 Q1
1 quarter
|
|
2922
Alkermes
ALKS
$7B
| $3.13M | ﹤0.01% |
76,070
+69,955
| +1,144% | +$3.19M |
2013 Q2
20 quarters
|
|
2923
WisdomTree Emerging Markets High Dividend Fund
DEM
$4.16B
| $3.13M | ﹤0.01% |
73,037
-7,577
| -9% | -$347K |
2013 Q2
20 quarters
|
|
2924
LiveRamp
RAMP
$2.29B
| $3.13M | ﹤0.01% |
104,526
+46,962
| +82% | +$1.29M |
2013 Q2
20 quarters
|
|
2925
KraneShares CSI China Internet ETF
KWEB
$4.55B
| $3.13M | ﹤0.01% |
52,524
+27,365
| +109% | +$1.67M |
2017 Q2
4 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2018 Portfolio in Review
As of Q2 2018, JP Morgan Chase held 5,918 positions worth $486B, up 4.2% from $467B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2018 filing shows 539 new, 2,430 increased, 2,080 reduced and 346 closed positions. Its largest new stake was Evergy: 3,598,208 shares worth $202M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2018 buy was Evergy: 3,598,208 shares worth $202M.
- JP Morgan Chase added most to Salesforce in Q2 2018, an estimated $1.09B increase.
- JP Morgan Chase's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.58B.
- JP Morgan Chase fully exited Time Warner Inc in Q2 2018, selling an estimated $764M.
- JP Morgan Chase's ten largest holdings make up 17% of its $486B portfolio in Q2 2018.
- JP Morgan Chase opened 539 new positions and closed 346 in Q2 2018.
- JP Morgan Chase's portfolio value rose 4.2% quarter-over-quarter to $486B.
Based on JP Morgan Chase's 13F filing for Q2 2018, filed 14 Aug 2018.